A new daily pill could reduce bad cholesterol levels by 60%, according to a new study. Enlicitide, which was developed by Merck, lowered “bad” LDL cholesterol by more than half in a global study ...
Despite guideline recommendations, evidence from randomized trials evaluating the appropriate low-density lipoprotein (LDL) cholesterol target for secondary prevention in patients with atherosclerotic ...
There are two main types of cholesterol in the body — HDL or “good” cholesterol, and LDL or “bad” cholesterol. Having higher levels of LDL cholesterol can potentially lead to atherosclerosis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results